Recombinant Human TLC domain-containing protein 2 (TLCD2)

What is TLCD2 and where is it expressed in human tissues?

TLCD2 (TLC domain-containing protein 2) is a transmembrane protein characterized by the presence of a TLC domain, distantly related to ER-localized ceramide synthases and translocation associated membrane proteins. It is expressed in various human tissues, with strongest expression in heart, muscle, liver, small intestine, and adipose tissue . Unlike many other TLC domain-containing proteins that localize to the endoplasmic reticulum, TLCD2 is found predominantly in the plasma membrane .

What is the primary function of TLCD2 in cellular membranes?

TLCD2 functions primarily as a regulator of membrane lipid composition by limiting the incorporation of long-chain polyunsaturated fatty acids (LCPUFAs) into membrane phospholipids . This regulation has direct consequences on membrane fluidity and cellular responses to lipid stress. TLCD2 appears to limit the formation of LCPUFA-containing phospholipids rather than promote their turnover, as demonstrated through isotope labeling studies .

How does TLCD2 relate to membrane phospholipid composition?

TLCD2 specifically regulates the fatty acid composition of phosphatidylethanolamine (PE), a major phospholipid in cellular membranes . Research shows that TLCD2 promotes the incorporation of monounsaturated fatty acids (MUFAs) into PEs . In Tlcd1/2 double-knockout (DKO) mice, hepatic MUFA-containing PE species are significantly reduced, with corresponding increases in saturated fatty acid (SFA)-containing PEs .

What experimental models are available for studying TLCD2 function?

Several experimental models have been developed to study TLCD2 function:

• Cell culture models: siRNA knockdown of TLCD2 in human HEK293 cells has been used to study its role in membrane fluidity regulation .

• Knockout mouse models: Tlcd1/2 double-knockout mice have been generated to study the physiological roles of these proteins in vivo .

• CRISPR-edited human cell lines: TLCD1/2 double-knockout clones in human hepatocellular carcinoma cell lines demonstrate conserved function in regulating PE composition .

• Protein overexpression models: Stable human HepG2 and HeLa cell lines expressing HA-tagged TLCD1 or TLCD2 proteins have been used for localization and interaction studies .

What methods are effective for analyzing TLCD2-mediated changes in membrane lipid composition?

Lipidomic analysis is the primary approach for assessing TLCD2-mediated changes in membrane lipid composition. Researchers have employed:

• Mass spectrometry-based lipidomics to quantify changes in phospholipid species composition in both whole cells and isolated organelles .

• Isotope labeling studies using 13C-labeled LCPUFAs (e.g., linoleic acid) to monitor incorporation and clearance rates in phospholipids .

• Subcellular fractionation to isolate mitochondria and analyze organelle-specific changes in phospholipid composition .

• Membrane fluidity assays to correlate lipid compositional changes with functional membrane properties .

How can researchers effectively measure TLCD2 protein interactions?

To map TLCD2 protein interactions, researchers have employed:

• Immunoprecipitation (IP) coupled with proteomics to identify protein interactors of HA-tagged TLCD1 and TLCD2 .

• Comparative interactomics between human TLCD proteins and their C. elegans homolog (FLD-1) to identify evolutionarily conserved interactions .

• Subcellular localization studies using tagged proteins and fluorescence microscopy to determine intracellular distribution and potential co-localization with other cellular components .

How does TLCD2 affect cellular responses to lipid stress?

TLCD2 plays a crucial role in cellular responses to lipid stress, particularly saturated fatty acid-induced membrane rigidification:

• Knockdown of TLCD2 protects human HEK293 cells from palmitic acid (PA)-induced membrane rigidification .

• TLCD2 knockdown also protects cells from PA-induced apoptosis, suggesting a role in lipotoxicity responses .

• TLCD2 knockdown suppresses membrane rigidification in cells where AdipoR2 has been knocked down, which increases sensitivity to the effect of PA on membrane rigidification .

What is the relationship between TLCD2 and cellular polyunsaturated fatty acid metabolism?

TLCD2 regulates PUFA incorporation into membrane phospholipids:

• Knockdown of TLCD2 increases the abundance of 18:2, 18:3, and 20:5 LCPUFAs in phosphatidylcholines (PCs) .

• When cells are cultivated with exogenous eicosapentaenoic acid (EPA), TLCD2 knockdown leads to excess accumulation of EPA in PCs and PEs, without affecting TAG storage or EPA uptake .

• Isotope labeling experiments with 13C-labeled linoleic acid (LA) show that TLCD2 knockdown causes increased incorporation of LA in PCs and PEs within 6 hours of incubation .

How does TLCD2 function relate to membrane fluidity regulation?

TLCD2 regulates membrane fluidity primarily by limiting the incorporation of LCPUFAs into membrane phospholipids:

• LCPUFAs are potent membrane fluidizers - as little as 1 μM of EPA or docosahexaenoic acid (DHA) can prevent membrane rigidification caused by 400 μM palmitic acid .

• By limiting LCPUFA incorporation into membrane phospholipids, TLCD2 influences the fluidity properties of cellular membranes .

• TLCD2 knockdown can protect against membrane rigidity phenotypes caused by deficiencies in other membrane homeostasis regulators, such as AdipoR2 .

What is the role of TLCD2 in mitochondrial membrane composition?

TLCD2 has been found to interact with mitochondria and regulate mitochondrial PE composition:

• Proteomic analysis of TLCD1/2 interactomes revealed enrichment for mitochondrial proteins, suggesting functional interaction with these organelles .

• In Tlcd1/2 double-knockout mice, mitochondrial PE composition is altered, with decreased MUFA-containing PE species compared to wild-type controls .

• The interaction with mitochondria appears to be evolutionarily conserved, as the C. elegans homolog FLD-1 shows similar mitochondrial associations .

How does TLCD2 contribute to metabolic disease pathophysiology?

Research has revealed potential roles for TLCD2 in metabolic disease:

• Tlcd1/2 double-knockout mice display attenuated development of non-alcoholic steatohepatitis (NASH) compared to control mice when fed a Western diet for 30 weeks .

• These mice exhibit reduced liver size, hepatic inflammation, fibrosis, and serum triglycerides compared to wild-type controls, despite comparable body composition and glucose tolerance .

• The protective effect against NASH development may be related to alterations in mitochondrial PE composition, which influences cellular metabolism and inflammatory responses .

What is known about lnc-TLCD2-1 and its role in cancer biology?

A long non-coding RNA associated with TLCD2 (lnc-TLCD2-1) has been implicated in cancer biology:

• lnc-TLCD2-1 can induce radiation resistance in colorectal cancer (CRC) .

• The mechanism appears to involve regulation of YY1/NF-κB-p65 by targeting miR-193a-5p .

• lnc-TLCD2-1 promotes proliferation of CRC cells, and patients with high expression of lnc-TLCD2-1 have shorter survival times .

• This suggests lnc-TLCD2-1 could serve as a potential biomarker for CRC prognosis and as a therapeutic target for radiation-resistant CRC .

How is TLCD2 function conserved between C. elegans and mammals?

TLCD2 function shows remarkable evolutionary conservation:

• The C. elegans homolog FLD-1 and mammalian TLCD1/2 both regulate membrane fluidity by limiting PUFA-containing phospholipid levels .

• Both FLD-1 mutations in C. elegans and TLCD2 knockdown in human cells suppress membrane rigidity phenotypes caused by deficiencies in other membrane homeostasis regulators .

• The subcellular localization to the plasma membrane (rather than ER) is conserved between FLD-1 and TLCD1/2 .

• Proteomic analyses reveal that both C. elegans FLD-1 and human TLCD1/2 interact with mitochondrial proteins, suggesting evolutionary conservation of this functional interaction .

What distinguishes TLCD2 from other TLC domain-containing proteins?

TLCD2 has several distinguishing features compared to other TLC domain-containing proteins:

• Unlike ceramide synthases (CERSs) and translocation associated membrane proteins (TRAMs), TLCD2 localizes to the plasma membrane rather than the endoplasmic reticulum .

• TLCD2 lacks critical motifs found in CERSs and TRAMs, indicating it is neither a ceramide synthase nor a translocation associated protein .

• TLCD2's function in regulating phospholipid fatty acid composition is distinct from the functions attributed to other TLC domain-containing proteins, which are suggested to act in lipid sensing, transport, or synthesis .

What are the current technical limitations in TLCD2 research?

Several technical challenges persist in TLCD2 research:

• Lipidomic analyses typically reflect global lipid composition rather than the composition of specific membrane compartments or domains, potentially masking localized effects of TLCD2 .

• When interpreting lipid supplementation experiments, researchers must exercise caution as uptake, metabolism, incorporation, subcellular localization, and turnover of different lipid species may vary substantially .

• The exact molecular mechanism by which TLCD2 limits LCPUFA incorporation into phospholipids remains to be fully elucidated, requiring more sophisticated biochemical approaches .

What are promising future research directions for TLCD2?

Based on current findings, several promising research directions emerge:

• Investigation of TLCD2's potential role in regulating the Lands cycle, through which phospholipids are actively remodeled by fatty acid exchange .

• Further exploration of TLCD2's interaction with mitochondria and its implications for mitochondrial function and metabolic disease .

• Detailed structural studies to understand how TLCD2 influences substrate selection by phospholipases or lysophospholipid acyltransferases .

• Examination of potential roles for TLCD2 in oxidative stress responses, given that FLD-1 mutants in C. elegans show enhanced oxidative stress responses when challenged with LCPUFA .

• Investigation of TLCD2's potential contributions to other membrane-dependent processes, such as calcium channel activity, insulin secretion, glucose transport, endocytosis, and TRPV channel activity .